An Unusual Cause of Superior Vena Cava Compression: Delayed Mediastinal Migration of Hyaluronic Acid Breast Fillers Authors: Ng Boon Hau, Low Hsueh Jing, Nik Nuratiqah Nik Abeed, Nor Safiqah Sharil, Nurul Aisyah Abd Rahman, Rose Azzlinda Osman, Nur Yazmin Yaacob, Mohd Ramzisham Abdul Rahman, Andrea Ban Yu‐Lin Published: 2026 ABSTRACT ABSTRACTInjectable breast fillers are increasingly used as minimally invasive alternatives to implants. Delayed complications such as migration and lymphadenopathy are increasingly reported. Mediastinal lymphadenopathy due to hyaluronic acid (HA) filler migration is rare. A woman in her 50s presented with progressive facial puffiness and chest wall venous distension. Six months earlier, an evaluation at another center had revealed mediastinal lymphadenopathy causing superior vena cava (SVC) compression. Video‐assisted thoracoscopic (VATS) biopsy revealed chronic inflammatory infiltrates. Further targeted history revealed prior bilateral breast augmentation using HA fillers. Repeat computed tomography demonstrated interval enlargement of the mediastinal lymphadenopathy with worsening SVC compression, together with radiological features suggestive of migration of filler material into the mediastinal nodes. Endobronchial ultrasound‐guided transbronchial needle aspiration yielded polymorphous lymphocytes. Magnetic resonance imaging of the breast demonstrated multiple bilateral lesions with irregular capsules. Following corticosteroid therapy, the patient experienced marked improvement in clinical symptoms, with a reduction in the mediastinal lesion on follow‐up imaging.Keywords: breast filler, hyaluronic acid, mediastinal lymphadenopathy, superior vena cava compression Introduction Injectable breast augmentation using soft‐tissue fillers is a minimally invasive alternative to conventional implants due to shorter recovery time and greater flexibility in breast contouring [1]. HA gained popularity due to its biodegradability and perceived lower risk of permanent complications, although delayed adverse events are increasingly recognized [2]. Reported complications include infection, granuloma formation, tissue necrosis, and filler migration to both regional and distant lymphatic structures, including mediastinal lymph nodes. Unlike conventional implants, injectable fillers lack a prosthetic barrier, potentially allowing dissemination through lymphatic channels and surrounding soft tissues [3]. Delayed presentations may occur years after injection and can mimic lymphoma, metastatic disease, granulomatous infection, sarcoidosis, or autoimmune disorders, particularly when cosmetic procedures are not initially disclosed [3]. Most reported cases involve silicone‐related lymphadenopathy, whereas HA‐associated mediastinal lymphadenopathy remains rare in the literature. We report a case of delayed migration of breast HA filler presenting as progressive mediastinal lymphadenopathy causing symptomatic SVC compression. The case highlights the diagnostic challenges of delayed filler migration and the importance of careful cosmetic history‐taking in unexplained mediastinal disease. Case Report A woman in her 50s presented with a 2‐month history of progressively worsening facial puffiness suggestive of superior vena cava obstruction (SVCO). Approximately 6 months before the current presentation, she had undergone extensive investigations for mediastinal lymphadenopathy at another center with an initial working diagnosis of malignancy. The chest radiograph showed mediastinal widening (Figure 1A). Contrast‐enhanced computed tomography (CECT) of the thorax demonstrated a solid, lobulated mass in the middle mediastinum measuring 3.5 × 3.0 × 6.2 cm (AP × W × CC). The lesion demonstrated mild enhancement predominantly at the anterosuperior aspect, with irregular margins and mild compression of the adjacent SVC (Figure 1B). A VATS biopsy was subsequently performed. Histopathological examination (HPE) demonstrated tissue infiltration predominantly by lymphocytes and plasma cells, with patchy lymphoid aggregates and focal aggregates of foamy histiocytes. Special stains, including Ziehl–Neelsen, periodic acid–Schiff (PAS), and Grocott methenamine silver (GMS), were negative. Immunohistochemical studies showed negative staining for CD10, BCL6, MUM1, cyclin D1, CD30, CKAE1/AE3, CD15, PAX5, CD3, CD20, CD79a, S100, and CD1a. The IgG4+/IgG+ plasma cell ratio was not elevated (< 40%). (A) Chest radiograph showed mediastinal widening. (B) Contrast‐enhanced computed tomography (CECT) of the thorax showed mediastinal lymphadenopathy compressing the superior vena cava (SVC). (C) Repeat CECT of the thorax showed interval enlargement of the mediastinal lymph nodes, with worsening compression of the SVC. (D&E) Breast magnetic resonance imaging (MRI) demonstrated multiple well‐defined oval‐shaped lesions of varying sizes scattered throughout the subcutaneous fat, breast parenchyma, and retroglandular region, extending to the anterior chest wall. (F) CECT of the thorax performed 6 weeks later demonstrated stable mediastinal lymphadenopathy without interval progression. Upon review of these findings at our center, the absence of definite evidence of malignancy, together with the chronic inflammatory and histiocytic features on histopathology, prompted further targeted history‐taking regarding prior cosmetic procedures and exposure to injectable substances. The patient subsequently disclosed a history of bilateral breast filler augmentation using HA fillers, which she had not initially considered relevant to her presentation. The initial procedure had been performed 8 years earlier, followed by a repeat augmentation 1 year before presentation. During the most recent procedure, 200 mL of hyaluronic acid filler had been reportedly injected into each breast. Clinical examination revealed facial congestion, dilated superficial veins over the chest wall, and tense skin involving both upper limbs and breasts. Respiratory examination was unremarkable. Her vital signs were stable: blood pressure 126/82 mmHg, heart rate 78 beats/min, temperature 37°C, and oxygen saturation 98% on room air. Laboratory investigations showed a total white blood cell count of 15.8 × 109/L, haemoglobin 11.6 g/dL, platelet count 437 × 109/L, and lactate dehydrogenase of 185.0 U/L. The Mantoux test was 0 mm. CXR showed widening of the superior mediastinum, corresponding to the underlying mediastinal nodal enlargement seen on subsequent imaging. Repeat CECT thorax demonstrated interval enlargement of the right mediastinal lymphadenopathy, now measuring 4.4 × 4.8 × 6.2 cm (AP × W × CC), with increased compression of the SVC (Figure 1C). Radiological findings were also suggestive of migration of breast filler material into the mediastinal lymph nodes. Microbiological investigations, including sputum acid‐fast bacilli (AFB) smear, Xpert Mycobacterium tuberculosis /Rifampicin (Xpert MTB/RIF), and cultures, were negative. The initial differential diagnoses included lymphoma, metastatic malignancy, granulomatous infection, and autoimmune‐related disease. The subsequent disclosure of prior breast filler augmentation, together with radiological features suggestive of filler migration, raised the additional possibility of mediastinal lymph node involvement secondary to migrated filler material and foreign‐body reaction. Although a repeat VATS biopsy was considered, the patient declined further surgical intervention. Endobronchial ultrasound‐guided transbronchial needle aspiration (EBUS‐TBNA) was performed as a minimally invasive alternative, targeting stations 7 and 4R. Following the procedure, the patient was initiated on dexamethasone 4 mg three times daily. At 1‐week follow‐up, significant improvement was observed, with resolution of facial puffiness and chest wall venous dilatation. Xpert MTB/RIF performed on the EBUS‐TBNA specimen was negative. Cytopathological examination demonstrated multiple polymorphous small lymphocytes with occasional neutrophils without evidence of malignancy. Serum IgG4 level was within the normal range, and autoimmune serological markers were negative. Subsequent breast MRI demonstrated multiple well‐defined oval bilateral breast lesions with irregular capsular appearances surrounding the injected filler material. An ill‐defined lobulated lesion was also identified in the right anterior mediastinum posterior to the brachiocephalic vein, corresponding to the lesion seen on previous CT imaging, measuring 3.2 × 2.2 cm (AP × W), representing an interval reduction (Figure 1D,E). Subcentimeter bilateral axillary lymph nodes with preserved fatty hilum were also identified. Following multidisciplinary team discussion, a final diagnosis of breast filler migration with associated foreign‐body inflammatory reaction causing mediastinal lymphadenopathy and SVC compression was established. In view of the marked symptomatic improvement and interval reduction in mediastinal lesion size following corticosteroid therapy, a conservative management approach was adopted. Repeat CECT of the thorax performed 6 weeks later demonstrated stable mediastinal lymphadenopathy without interval progression (Figure 1F). The patient remains under ongoing surveillance. Discussion This case represents an unusual presentation of delayed mediastinal lymphadenopathy secondary to breast HA filler migration, resulting in clinically significant SVC compression. The diagnosis proved particularly challenging because the patient initially underwent extensive evaluation for mediastinal malignancy, including video‐assisted thoracoscopic biopsy and subsequent EBUS‐guided sampling, both of which failed to demonstrate malignancy, tuberculosis, lymphoma, IgG4‐related disease, or other specific inflammatory disorders. Only following detailed targeted history taking was a prior history of bilateral breast augmentation using HA fillers identified, providing a unifying explanation for the mediastinal lymphadenopathy and progressive SVC compression. Migration of filler material is believed to occur predominantly through lymphatic dissemination. The breast drains primarily via the axillary, internal mammary, and transpectoral lymphatic pathways [4]. When lymphatic drainage is altered, or large filler volumes are injected, retrograde dissemination and collateral lymphatic spread toward mediastinal nodal stations may occur [4, 5, 6, 7]. Systematic reviews of filler migration have reported that axillary lymph nodes are most commonly involved, followed by internal mammary, cervical, and supraclavicular chains, while mediastinal involvement remains distinctly uncommon [4]. Most published cases of filler‐associated lymphadenopathy involve silicone leakage or implant‐related silicone migration. In contrast, mediastinal lymphadenopathy associated with HA filler appears to be exceptionally rare, with only a limited number of reports in the literature. The rarity of this presentation may reflect the biodegradable nature of HA, its relatively shorter tissue persistence, and the under‐recognition of delayed migration‐related complications [8]. In this case, the large volume of filler administered during the repeat augmentation procedure may have contributed to delayed lymphatic dissemination and progressive mediastinal involvement. Radiological assessment played a pivotal role in establishing the diagnosis. Initial CT imaging demonstrated a lobulated mediastinal lesion causing compression of the SVC without calcification or definitive features of malignancy. Repeat imaging revealed interval enlargement of the right mediastinal lymphadenopathy with persistent compression of the SVC, together with findings suggestive of migration of breast filler material into the mediastinal nodes. The subsequent reduction in nodal size following corticosteroid therapy further supported an inflammatory or foreign‐body process rather than neoplastic progression. Chest CT remains the imaging modality of choice for evaluating mediastinal lymphadenopathy as it allows detailed assessment of nodal distribution, degree of vascular compression, interval disease progression, and associated breast abnormalities that may suggest filler migration [9]. Histopathological confirmation of filler‐associated lymphadenopathy is often challenging, particularly in delayed presentations such as the present case. Silicone‐associated lymphadenopathy classically demonstrates granulomatous inflammation with multinucleated giant cells, a foreign‐body reaction, vacuolated histiocytes, and silicone‐laden macrophages [10, 11]. In contrast, HA fillers appear to have a lower propensity to induce prominent granulomatous responses [11]. In the present case, the histopathological examination demonstrated predominantly lymphoplasmacytic infiltration with foamy histiocytes, without classical foreign‐body granuloma formation. The delayed presentation, occurring many years after the initial augmentation and approximately 1 year after the repeat injection, may have contributed to the absence of characteristic cytopathological features, as progressive degradation and resorption of HA could alter the histological appearance over time. Therefore, the absence of classic granulomatous findings should not exclude the possibility of filler‐associated disease, particularly when supported by compatible radiological findings and relevant cosmetic history. Management of filler‐associated mediastinal lymphadenopathy remains individualized, as standardized treatment guidelines are currently lacking. Reported therapeutic approaches include observation, corticosteroid therapy, hyaluronidase administration for localized HA‐related nodules, surgical excision of accessible lesions, removal of implants when present, and treatment of complications such as vascular compression [12]. Although hyaluronidase may be effective for superficial or localized HA deposits, its role is likely limited once filler material has migrated into mediastinal lymphatic structures. Surgical excision of mediastinal involvement may also be technically challenging and may not necessarily alter the disease progression. In our patient, conservative management was selected because symptoms improved rapidly after dexamethasone therapy, with a reduction in nodal size and no radiological progression at the 6‐week follow‐up. The major learning point from this case is that a history of cosmetic breast filler procedures should be actively sought in patients presenting with unexplained mediastinal lymphadenopathy, particularly when conventional investigations remain inconclusive. Recognition of delayed HA migration is especially important because HA‐associated mediastinal lymphadenopathy appears to be considerably rarer than silicone‐related disease and may present with atypical or non‐specific histopathological findings, particularly in delayed presentations. In the present case, the diagnosis was established through careful correlation of the temporal relationship with repeat filler injection, radiological evidence suggestive of filler migration, exclusion of alternative etiologies, and multidisciplinary clinical assessment. Author Contributions N.B.H., L.H.J., and N.N.N.A. wrote up the case under the continuous supervision of A.Y.L.B. They discussed the case presentation, investigations, and patient management. N.S.S., N.A.A.R., N.Y.Y., M.R.A.R., and R.A.O. were involved in the patient's management. N.B.H. and A.Y.L.B. supervised and guided the patient's management. Consent The authors declare that written informed consent was obtained for the publication of this manuscript and accompanying images using the consent form provided by the Journal. Conflicts of Interest Andrea Ban Yu‐Lin is an Editorial Board member of Respirology Case Reports and a co‐author of this article. She was excluded from all editorial decision‐making related to the acceptance of this article for publication. Hau N. B., Jing L. H., Abeed N. N. N., et al., “An Unusual Cause of Superior Vena Cava Compression: Delayed Mediastinal Migration of Hyaluronic Acid Breast Fillers,” Respirology Case Reports 14, no. 9 (2026): e70752, 10.1002/rcr2.70752. Associate Editor: Yoshiyuki Ozawa Data Availability Statement The data that support the findings of this study are available from the corresponding author upon reasonable request. References Associated Data Data Availability Statement The data that support the findings of this study are available from the corresponding author upon reasonable request.